BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 13, Issue 36
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (2770)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-3) series.
Item 
Count 
PDF337
HTML2015
Figures (1-3)418
 Sum=2770
Sep 28, 2007 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Timm J, Roggendorf M. Sequence diversity of hepatitis C virus: Implications for immune control and therapy. World J Gastroenterol 2007; 13(36): 4808-4817 [PMID: 17828811 DOI: 10.3748/wjg.v13.i36.4808]
URL: https://www.wjgnet.com/1007-9327/full/v13/i36/4808.htm
Number Citing Articles
1
Hadas Dvory‐Sobol, Bin Han, Julia Lu, Mei Yu, Rudolf K. Beran, Guofeng Cheng, Ross Martin, Evguenia Svarovskaia, Hongmei Mo. In vitro resistance profile of hepatitis C virus NS5A inhibitor velpatasvir in genotypes 1 to 6. Journal of Viral Hepatitis 2019; 26(8): 991 doi: 10.1111/jvh.13116
2
Tom S. Chan, Marc Bilodeau. Endogenous Toxins. 2009; : 595 doi: 10.1002/9783527628100.ch24
3
Michael J. Bouchard, Sonia Navas-Martin. Hepatitis B and C virus hepatocarcinogenesis: Lessons learned and future challenges. Cancer Letters 2011; 305(2): 123 doi: 10.1016/j.canlet.2010.11.014
4
Zobair M. Younossi, Ancha Baranova, Arian Afendy, Rochelle Collantes, Maria Stepanova, Ganiraju Manyam, Anita Bakshi, Christopher L. Sigua, Joanne P. Chan, Ayuko A. Iverson, Christopher D. Santini, Sheng‐Yung P. Chang. Early gene expression profiles of patients with chronic hepatitis C treated with pegylated interferon‐alfa and ribavirin†. Hepatology 2009; 49(3): 763 doi: 10.1002/hep.22729
5
Rohan Janardhan Meshram, Gunderao Hanumantrao Kathwate, Rajesh Nivarti Gacche. Progress, evolving therapeutic/diagnostic approaches, and challenges in the management of hepatitis C virus infections. Archives of Virology 2022; 167(3): 717 doi: 10.1007/s00705-022-05375-0
6
Stephanie Jiménez Irausquin, Austin L. Hughes. Conflicting selection pressures target the NS3 protein in hepatitis C virus genotypes 1a and 1b. Virus Research 2010; 147(2): 202 doi: 10.1016/j.virusres.2009.11.001
7
José Manuel Echevarría, Ana Avellón. Utilidad de la biología molecular en el diagnóstico microbiológico de las hepatitis virales. Enfermedades Infecciosas y Microbiología Clínica 2008; 26: 66 doi: 10.1016/S0213-005X(08)76543-1
8
Brendan A. Palmer, Isabelle Moreau, John Levis, Ciara Harty, Orla Crosbie, Elizabeth Kenny-Walsh, Liam J. Fanning. Insertion and recombination events at hypervariable region 1 over 9.6 years of hepatitis C virus chronic infection.  Journal of General Virology 2012; 93(12): 2614 doi: 10.1099/vir.0.045344-0
9
Cynthia K.Y. Ho, Matthijs R.A. Welkers, Xiomara V. Thomas, James C. Sullivan, Tara L. Kieffer, Henk W. Reesink, Sjoerd P.H. Rebers, Menno D. de Jong, Janke Schinkel, Richard Molenkamp. A comparison of 454 sequencing and clonal sequencing for the characterization of hepatitis C virus NS3 variants. Journal of Virological Methods 2015; 219: 28 doi: 10.1016/j.jviromet.2015.03.018
10
Balkumar Reddy Panyala, Rathindra Mohan Mukherjee, Himaja Devarakonda, Sivasathish Tadivaka, Nagaraja Rao Padaki, Mithun Sharma, Nageshwar Reddy Duvvuru. Genotype distribution in relation to viral load in a large cohort of Indian patients with chronic hepatitis C virus infection: A retrospective analysis. Indian Journal of Gastroenterology 2019; 38(2): 110 doi: 10.1007/s12664-019-00934-x
11
Guoping Du, Xiaoshan Li, Taha Hussein Musa, Yu Ji, Bo Wu, Yan He, Qian Ni, Ling Su, Wei Li, You Ge. The nationwide distribution and trends of hepatitis C virus genotypes in mainland China. Journal of Medical Virology 2019; 91(3): 401 doi: 10.1002/jmv.25311
12
Chayan Bhattacharjee, Suman K. Nandy, Pratik Das, Aparna Mukhopadhyay. Differential interaction strategies of hepatitis c virus genotypes during entry – An in silico investigation of envelope glycoprotein E2 - CD81 interaction. Infection, Genetics and Evolution 2019; 69: 48 doi: 10.1016/j.meegid.2019.01.008
13
Nicholas A. Meanwell, John F. Kadow, Paul M. Scola. Annual Reports in Medicinal Chemistry Volume 44. Annual Reports in Medicinal Chemistry 2009; 44: 397 doi: 10.1016/S0065-7743(09)04420-0
14
Michael A. Joyce, D. Lorne J. Tyrrell. The cell biology of hepatitis C virus. Microbes and Infection 2010; 12(4): 263 doi: 10.1016/j.micinf.2009.12.012
15
Micah Oyaro, John Wylie, Chien-Yu Chen, Raphael O. Ondondo, Anna Kramvis. Human immunodeficiency virus infection predictors and genetic diversity of hepatitis B virus and hepatitis C virus co-infections among drug users in three major Kenyan cities. Southern African Journal of HIV Medicine 2018; 19(1) doi: 10.4102/sajhivmed.v19i1.737
16
Hui-Chun Li, Shih-Yen Lo. Hepatitis C virus: Virology, diagnosis and treatment. World Journal of Hepatology 2015; 7(10): 1377-1389 doi: 10.4254/wjh.v7.i10.1377
17
Farakh Javed, Sobia Manzoor. HCV non-structural NS4A protein of genotype 3a induces mitochondria mediated death by activating Bax and the caspase cascade. Microbial Pathogenesis 2018; 124: 346 doi: 10.1016/j.micpath.2018.08.065
18
L. Alvarez‐Lajonchere, N. H. Shoukry, B. Grá, Y. Amador‐Cañizares, F. Helle, N. Bédard, I. Guerra, C. Drouin, J. Dubuisson, E. E. González‐Horta, G. Martínez, J. Marante, Z. Cinza, M. Castellanos, S. Dueñas‐Carrera. Immunogenicity of CIGB‐230, a therapeutic DNA vaccine preparation, in HCV‐chronically infected individuals in a Phase I clinical trial. Journal of Viral Hepatitis 2009; 16(3): 156 doi: 10.1111/j.1365-2893.2008.01058.x
19
Graham S. Cooke. Manson's Tropical Diseases. 2024; : 152 doi: 10.1016/B978-0-7020-7959-7.00018-X
20
Moataza H. Omran, Wael Nabil, Samar S. Youssef, Mervat El-Sayed, Mostafa K. El Awady. Heterogeneity and New Epitopes of Hepatitis C Virus Genotype 4. Hepatitis Monthly 2013; 13(8) doi: 10.5812/hepatmon.10521
21
Pierina D’Angelo, Rossana Celeste Jaspe, Carmen Luisa Loureiro, Cristina Gutiérrez, María Zulay Sulbarán, Yoneira Sulbarán, Felix Toro, Flor Helene Pujol. Desempeño de métodos moleculares para la identificación de subtipos poco comunes del virus de hepatitis C genotipo 2. Biomédica 2018; 38(2): 282 doi: 10.7705/biomedica.v38i0.3864
22
Hyun Lee, Tian Zhu, Kavankumar Patel, Yan-Yan Zhang, Lena Truong, Kirk E. Hevener, Joseph L. Gatuz, Gitanjali Subramanya, Hyun-Young Jeong, Susan L. Uprichard, Michael E. Johnson, Birke Bartosch. High-Throughput Screening (HTS) and Hit Validation to Identify Small Molecule Inhibitors with Activity against NS3/4A proteases from Multiple Hepatitis C Virus Genotypes. PLoS ONE 2013; 8(10): e75144 doi: 10.1371/journal.pone.0075144
23
Teshiwal Deress, Yihenew Million, Teshome Belachew, Mohabaw Jemal, Mekonnen Girma, Gianandrea Pasquinelli. Seroprevalence of Hepatitis C Viral Infection in Ethiopia: A Systematic Review and Meta-Analysis. The Scientific World Journal 2021; 2021: 1 doi: 10.1155/2021/8873389
24
Abdel-Hameed Ibrahim Mohamed Ebid, Ossama Ashraf Ahmed, Sara Hassan Agwa, Sara Mohamed Abdel-Motaleb, Radwa Samir Hagag. Impact of IL28B gene polymorphism on efficacy and safety of direct acting antivirals in hepatitis C Egyptian patients. International Journal of Clinical Pharmacy 2020; 42(4): 1207 doi: 10.1007/s11096-020-01085-2
25
Semra ÖZ, Mehmet KÖROĞLU, Ahmet ÖZBEK, Tayfur DEMİRAY, Oğuz KARABAY, Gülay TRAK, Mustafa ALTINDİŞ. Sakarya İlinde Hepatit C Virüs Genotip Dağılımı; Üç Yıllık Retrospektif Çalışma. Online Türk Sağlık Bilimleri Dergisi 2019; 4(4): 444 doi: 10.26453/otjhs.480164
26
Yuan‐Jie Ding, Chung‐Kuang Lu, Wei‐Ming Chen, Shui‐Yi Tung, Kuo‐Liang Wei, Chen‐Heng Shen, Yung‐Yu Hsieh, Chih‐Wei Yen, Kao‐Chi Chang, Wen‐Nan Chiu, Chao‐Hung Hung, Sheng‐Nan Lu, Te‐Sheng Chang. Pangenotypic direct‐acting antiviral agents for mixed genotype hepatitis C infection: A real‐world effectiveness analysis. Journal of Gastroenterology and Hepatology 2021; 36(10): 2911 doi: 10.1111/jgh.15546
27
Michael A. Joyce, Kathie-Anne Walters, Sue-Ellen Lamb, Mathew M. Yeh, Lin-Fu Zhu, Norman Kneteman, Jason S. Doyle, Michael G. Katze, D. Lorne Tyrrell, Grant McFadden. HCV Induces Oxidative and ER Stress, and Sensitizes Infected Cells to Apoptosis in SCID/Alb-uPA Mice. PLoS Pathogens 2009; 5(2): e1000291 doi: 10.1371/journal.ppat.1000291
28
F.S. Alhamlan, M.N. Al‐Ahdal, N.Z. Khalaf, A.A. Abdo, F.M. Sanai, H.I. Al‐Ashgar, M. ElHefnawi, A. Zaid, A.A. Al‐Qahtani. Hepatitis C virus genotype 1: How genetic variability of the core protein affects the response to pegylated‐interferon and ribavirin therapy. Journal of Medical Virology 2014; 86(2): 224 doi: 10.1002/jmv.23823
29
Aybike Birerdinc, Arian Afendy, Maria Stepanova, Issah Younossi, Ancha Baranova, Zobair M. Younossi. Gene expression profiles associated with depression in patients with chronic hepatitis C (CH‐C). Brain and Behavior 2012; 2(5): 525 doi: 10.1002/brb3.72
30
Chao Chen, Hui Qiu, Jian Gong, Qing Liu, Han Xiao, Xin-Wen Chen, Bin-Lian Sun, Rong-Ge Yang. (−)-Epigallocatechin-3-gallate inhibits the replication cycle of hepatitis C virus. Archives of Virology 2012; 157(7): 1301 doi: 10.1007/s00705-012-1304-0
31
M. Estée Török. Manson's Tropical Infectious Diseases. 2014; : 112 doi: 10.1016/B978-0-7020-5101-2.00014-5
32
Arnolfo Petruzziello, Samantha Marigliano, Giovanna Loquercio, Anna Cozzolino, Carmela Cacciapuoti. Global epidemiology of hepatitis C virus infection: An up-date of the distribution and circulation of hepatitis C virus genotypes. World Journal of Gastroenterology 2016; 22(34): 7824-7840 doi: 10.3748/wjg.v22.i34.7824
33
Claudia Palladino, Ifeanyi Jude Ezeonwumelu, Rute Marcelino, Verónica Briz, Inês Moranguinho, Fátima Serejo, José Fernando Velosa, Rui Tato Marinho, Pedro Borrego, Nuno Taveira. Epidemic history of hepatitis C virus genotypes and subtypes in Portugal. Scientific Reports 2018; 8(1) doi: 10.1038/s41598-018-30528-0
34
A. Birerdinc, A. Afendy, M. Stepanova, I. Younossi, G. Manyam, A. Baranova, Z. M. Younossi. Functional pathway analysis of genes associated with response to treatment for chronic hepatitis C. Journal of Viral Hepatitis 2010; 17(10): 730 doi: 10.1111/j.1365-2893.2009.01235.x
35
Maryann C. Ezeilo, Godwill A. Engwa, Romanus I. Iroha, Damian N. Odimegwu. High Anti-HCV Seroprevalence and Low Performance of ICT Strip in Diagnosing Hepatitis C Virus Infection in Children in Enugu Metropolis. The Open Virology Journal 2018; 12(1): 149 doi: 10.2174/1874357901812010149
36
Nicholas Israel Nii-Trebi, Charles Addoquaye Brown, Yaa Difie Osei, William Kwabena Ampofo, Alexander Kwadwo Nyarko. Core encoding sequences of Hepatitis C virus in Ghanaian blood donors are predominantly mosaics of different genotype 2 strains and cannot distinguish subtypes. BMC Infectious Diseases 2019; 19(1) doi: 10.1186/s12879-019-4155-4
37
Susanne Modrow, Uwe Truyen, Hermann Schätzl. Molekulare Virologie. 2021; : 163 doi: 10.1007/978-3-662-61781-6_14
38
Mustafizur Rahman, Mohammad Enayet Hossain, Mokibul Hassan Afrad, Rashedul Hasan, Mahfuza Rahman, Md. Safiullah Sarker, Tasnim Azim. Hepatitis C virus infections among clients attending an HIV testing and counseling center in Dhaka, Bangladesh. Journal of Medical Virology 2018; 90(2): 383 doi: 10.1002/jmv.24955
39
Karine Vieira Gaspareto, Roberto Marques Ribeiro, Fernanda de Mello Malta, Michele Soares Gomes-Gouvêa, Nair Hideko Muto, Maria Cassia Mendes-Correa, Andrei Rozanski, Flair José Carrilho, Ester Cerdeira Sabino, João Renato Rebello Pinho. HCV inter-subtype 1a/1b recombinant detected by complete-genome next-generation sequencing. Archives of Virology 2016; 161(8): 2161 doi: 10.1007/s00705-016-2889-5
40
Varsha Gupta, Manjistha Sengupta, Jaya Prakash, Baishnab Charan Tripathy. Basic and Applied Aspects of Biotechnology. 2017; : 125 doi: 10.1007/978-981-10-0875-7_6
41
Katja Pfafferott, Silvana Gaudieri, Axel Ulsenheimer, Ian James, Malte Heeg, David Nolan, Mina John, Andri Rauch, Simon Mallal, Andrew Lucas, Paul Klenerman, Helmut M. Diepolder, Michaela Lucas, Jean-Pierre Vartanian. Constrained Pattern of Viral Evolution in Acute and Early HCV Infection Limits Viral Plasticity. PLoS ONE 2011; 6(2): e16797 doi: 10.1371/journal.pone.0016797
42
Jane P. Messina, Isla Humphreys, Abraham Flaxman, Anthony Brown, Graham S. Cooke, Oliver G. Pybus, Eleanor Barnes. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 2015; 61(1): 77 doi: 10.1002/hep.27259
43
Zobair M. Younossi, Dolores Limongi, Maria Stepanova, Mariaelena Pierobon, Arian Afendy, Rohini Mehta, Ancha Baranova, Lance. Liotta, Emanuel. Petricoin. Protein Pathway Activation Associated with Sustained Virologic Response in Patients with Chronic Hepatitis C Treated with Pegylated Interferon (PEG-IFN) and Ribavirin (RBV). Journal of Proteome Research 2011; 10(2): 774 doi: 10.1021/pr100923u
44
Jason W. Rausch, Adam A. Capoferri, Mary Grace Katusiime, Sean C. Patro, Mary F. Kearney. Low genetic diversity may be an Achilles heel of SARS-CoV-2. Proceedings of the National Academy of Sciences 2020; 117(40): 24614 doi: 10.1073/pnas.2017726117
45
Eric Lawitz, Jenny C Yang, Luisa M Stamm, James G Taylor, Guofeng Cheng, Diana M Brainard, Michael D Miller, Hongmei Mo, Hadas Dvory-Sobol. Characterization of HCV Resistance from a 3-Day Monotherapy Study of Voxilaprevir, a Novel Pangenotypic NS3/4A Protease Inhibitor. Antiviral Therapy 2018; 23(4): 325 doi: 10.3851/IMP3202
46
N. Bhardwaj, M. Ragonnet‐Cronin, B. Murrell, K. Chodavarapu, R. Martin, S. Chang, M. D. Miller, J. J. Feld, M. Sulkowski, A. Mangia, J. O. Wertheim, A. Osinusi, J. McNally, D. Brainard, H. Mo, E. S. Svarovskaia. Intrapatient viral diversity and treatment outcome in patients with genotype 3a hepatitis C virus infection on sofosbuvir‐containing regimens. Journal of Viral Hepatitis 2018; 25(4): 344 doi: 10.1111/jvh.12825
47
Gary P. Wang, Scott A. Sherrill-Mix, Kyong-Mi Chang, Chris Quince, Frederic D. Bushman. Hepatitis C Virus Transmission Bottlenecks Analyzed by Deep Sequencing. Journal of Virology 2010; 84(12): 6218 doi: 10.1128/JVI.02271-09
48
Hye Jin Yang, Ju Yeon Ryoo, Bong Kyu Yoo. Meta-analysis of the efficacy and safety of sofosbuvir for the treatment of hepatitis C virus infection. International Journal of Clinical Pharmacy 2015; 37(5): 698 doi: 10.1007/s11096-015-0144-x
49
Manish Dwivedi, Aditya Dwivedi, Debalina Mukherjee. An Insight into Hepatitis C Virus: In Search of Promising Drug Targets. Current Drug Targets 2023; 24(14): 1127 doi: 10.2174/0113894501265769231020031857
50
Julio Daimar Oliveira Correa, José Artur Bogo Chies. The COVID-19 Pandemic Affected Hepatitis C Virus Circulation and Genotypic Frequencies—Implications for Hepatitis C Prevention, Treatment and Research. Epidemiologia 2024; 5(2): 160 doi: 10.3390/epidemiologia5020011
51
Aybike Birerdinc, Zobair M Younossi. Emerging therapies for hepatitis C virus. Expert Opinion on Emerging Drugs 2010; 15(4): 535 doi: 10.1517/14728214.2010.502527
52
Arnolfo Petruzziello, Samantha Marigliano, Giovanna Loquercio, Carmela Cacciapuoti. Hepatitis C virus (HCV) genotypes distribution: an epidemiological up-date in Europe. Infectious Agents and Cancer 2016; 11(1) doi: 10.1186/s13027-016-0099-0
53
Manola Comar, Francesco De Seta, Nunzia Zanotta, Serena Del Bue, Pasquale Ferrante. Sexually Transmitted Infections. 2020; : 107 doi: 10.1007/978-3-030-02200-6_6
54
Saba Khaliq, Shah Jahan, Asim Pervaiz. Sequence variability of HCV Core region: Important predictors of HCV induced pathogenesis and viral production. Infection, Genetics and Evolution 2011; 11(3): 543 doi: 10.1016/j.meegid.2011.01.017
55
Rashied Mohammed Rashied, Hala Fouad Kasim, Sabah A. Hamid A. Rahman. Article Review: The Hepatic Physiology and Pathophysiology of Different Types of Hepatitis. Journal for Research in Applied Sciences and Biotechnology 2024; 3(1): 193 doi: 10.55544/jrasb.3.1.31
56
Phillip A Furman, Angela M Lam, Eisuke Murakami. Nucleoside Analog Inhibitors of Hepatitis C Viral Replication: Recent Advances, Challenges and Trends. Future Medicinal Chemistry 2009; 1(8): 1429 doi: 10.4155/fmc.09.88
57
Tania M. Welzel, Neeru Bhardwaj, Charlotte Hedskog, Krishna Chodavarapu, Gregory Camus, John McNally, Diana Brainard, Michael D. Miller, Hongmei Mo, Evguenia Svarovskaia, Ira Jacobson, Stefan Zeuzem, Kosh Agarwal. Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses. Journal of Hepatology 2017; 67(2): 224 doi: 10.1016/j.jhep.2017.03.014
58
Arnolfo Petruzziello. Epidemiology of Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) Related Hepatocellular Carcinoma. The Open Virology Journal 2018; 12(1): 26 doi: 10.2174/1874357901812010026
59
Jiwoong Kim, Yongju Ahn, Kichan Lee, Sung Hee Park, Sangsoo Kim. A classification approach for genotyping viral sequences based on multidimensional scaling and linear discriminant analysis. BMC Bioinformatics 2010; 11(1) doi: 10.1186/1471-2105-11-434
60
Muhammad Imran, Yasir Waheed, Sobia Manzoor, Muhammad Bilal, Waseem Ashraf, Muhammad Ali, Muhammad Ashraf. Interaction of Hepatitis C virus proteins with pattern recognition receptors. Virology Journal 2012; 9(1) doi: 10.1186/1743-422X-9-126
61
Susanne Ziegler, Kathrin Skibbe, Andreas Walker, Xiaoyu Ke, Falko M. Heinemann, Andreas Heinold, Juk Yee Mok, Wim J. E. van Esch, Dongliang Yang, Matthias Wölfl, Jörg Timm, M. S. Diamond. Impact of Sequence Variation in a Dominant HLA-A*02-Restricted Epitope in Hepatitis C Virus on Priming and Cross-Reactivity of CD8 + T Cells . Journal of Virology 2014; 88(19): 11080 doi: 10.1128/JVI.01590-14
62
Janie B. Trepanier, Jerome E. Tanner, Caroline Alfieri. Reduction in intracellular HCV RNA and virus protein expression in human hepatoma cells following treatment with 2′-O-methyl-modified anti-core deoxyribozyme. Virology 2008; 377(2): 339 doi: 10.1016/j.virol.2008.04.022
63
Stephanie Jiménez Irausquin, Austin L. Hughes. Distinctive pattern of sequence polymorphism in the NS3 protein of hepatitis C virus type 1b reflects conflicting evolutionary pressures. Journal of General Virology 2008; 89(8): 1921 doi: 10.1099/vir.0.2008/000992-0
64
Arnolfo Petruzziello, Samantha Marigliano, Giovanna Loquercio, Nicola Coppola, Mauro Piccirillo, Maddalena Leongito, Rosa Azzaro, Francesco Izzo, Gerardo Botti. Hepatitis C Virus (HCV) genotypes distribution among hepatocellular carcinoma patients in Southern Italy: a three year retrospective study. Infectious Agents and Cancer 2017; 12(1) doi: 10.1186/s13027-017-0162-5
65
R. K. Gieseler, G. Marquitan, M. Schlattjan, J.-P. Sowa, L. P. Bechmann, J. Timm, M. Roggendorf, G. Gerken, S. L. Friedman, A. Canbay. Hepatocyte apoptotic bodies encasing nonstructural HCV proteins amplify hepatic stellate cell activation: implications for chronic hepatitis C. Journal of Viral Hepatitis 2011; 18(11): 760 doi: 10.1111/j.1365-2893.2010.01362.x
66
Marianne Ruhl, Patrick Chhatwal, Heiko Strathmann, Thomas Kuntzen, Dorothea Bankwitz, Kathrin Skibbe, Andreas Walker, Falko M. Heinemann, Peter A. Horn, Todd M. Allen, Daniel Hoffmann, Thomas Pietschmann, Jörg Timm. Escape from a Dominant HLA-B*15-Restricted CD8 + T Cell Response against Hepatitis C Virus Requires Compensatory Mutations outside the Epitope . Journal of Virology 2012; 86(2): 991 doi: 10.1128/JVI.05603-11
67
Darja Kanduc, Luciana Tessitore, Guglielmo Lucchese, Anthony Kusalik, Emanuel Farber, Francesco M. Marincola. Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response. Cancer Immunology, Immunotherapy 2008; 57(8): 1215 doi: 10.1007/s00262-008-0456-y
68
Palak K. Parikh, Nisha H. Parikh, Mahalakshmi B, Ketan M. Ranch, Sai H.S. Boddu, Jayachandra Babu R, Amit K. Tiwari. Developments in small molecule antiviral drugs against hepatitis B and C viruses: FDA approved therapies and new drugs in clinical trials. Arabian Journal of Chemistry 2023; 16(8): 105013 doi: 10.1016/j.arabjc.2023.105013
69
Lotte Coelmont, Suzanne Kaptein, Jan Paeshuyse, Inge Vliegen, Jean-Maurice Dumont, Grégoire Vuagniaux, Johan Neyts. Debio 025, a Cyclophilin Binding Molecule, Is Highly Efficient in Clearing Hepatitis C Virus (HCV) Replicon-Containing Cells When Used Alone or in Combination with Specifically Targeted Antiviral Therapy for HCV (STAT-C) Inhibitors. Antimicrobial Agents and Chemotherapy 2009; 53(3): 967 doi: 10.1128/AAC.00939-08
70
Françoise Stoll-Keller, Heidi Barth, Samira Fafi-Kremer, Mirjam B Zeisel, Thomas F Baumert. Development of hepatitis C virus vaccines: challenges and progress. Expert Review of Vaccines 2009; 8(3): 333 doi: 10.1586/14760584.8.3.333
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345